Evolution of a New Class of VEGFR-2 Inhibitors from Scaffold Morphing and Redesign.

about

Evolution of a New Class of VEGFR-2 Inhibitors from Scaffold Morphing and Redesign.

Item

http://www.wikidata.org/entity/Q40277873

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Evolution of a New Class of VEGFR-2 Inhibitors from Scaffold Morphing and Redesign.

@en

type

Item

label

Evolution of a New Class of VEGFR-2 Inhibitors from Scaffold Morphing and Redesign.

@en

prefLabel

Evolution of a New Class of VEGFR-2 Inhibitors from Scaffold Morphing and Redesign.

@en

P1476

Evolution of a New Class of VEGFR-2 Inhibitors from Scaffold Morphing and Redesign.

@en

P2093

Fang Liu

http://www.w3.org/2001/XMLSchema#string

Karen Anderson

http://www.w3.org/2001/XMLSchema#string

Nello Mainolfi

http://www.w3.org/2001/XMLSchema#string

Rajeshri Karki

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor

Discovery of novel benzimidazoles as potent inhibitors of TIE-2 and VEGFR-2 tyrosine kinase receptors

Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors

The biology of vascular endothelial growth factor

The discovery of N-(1,3-thiazol-2-yl)pyridin-2-amines as potent inhibitors of KDR kinase.

Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes.

VEGF receptor signal transduction.

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

Antiangiogenic agents: an update on small molecule VEGFR inhibitors.

Recent advances in antiangiogenic agents with VEGFR as target.

P304

363-367

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACSMEDCHEMLETT.5B00486

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27096042

http://www.w3.org/2001/XMLSchema#string

P932

4834667

http://www.w3.org/2001/XMLSchema#string